Targeting hepatic glucose metabolism in the treatment of type 2 diabetes.
about
Quebrachitol: Global Status and Basic Research.Momordica charantia: a popular health-promoting vegetable with multifunctionality.CRISPR/Cas9: at the cutting edge of hepatology.Deficiency of COX7RP, a mitochondrial supercomplex assembly promoting factor, lowers blood glucose level in mice.Ccdc3: A New P63 Target Involved in Regulation Of Liver Lipid Metabolism.Catabolic and anabolic faces of insulin resistance and their disorders: a new insight into circadian control of metabolic disorders leading to diabetes.Structural constraints and importance of caffeic acid moiety for anti-hyperglycemic effects of caffeoylquinic acids from chicory.FAM3C activates HSF1 to suppress hepatic gluconeogenesis and attenuate hyperglycemia of type 1 diabetic mice.Exposures to arsenite and methylarsonite produce insulin resistance and impair insulin-dependent glycogen metabolism in hepatocytes.A New Potent Inhibitor of Glycogen Phosphorylase Reveals the Basicity of the Catalytic Site.H19 lncRNA alters methylation and expression of Hnf4α in the liver of metformin-exposed fetuses.Inhibition of α-glucosidase, α-amylase, and aldose reductase by potato polyphenolic compounds.Characterization of an insulinotropic peptide from skin secretions of Odorrana andersonii.SCP4: A Small Nuclear Phosphatase Having a Big Effect on FoxOs in Gluconeogenesis.The long non-coding RNA Gm10768 activates hepatic gluconeogenesis by sequestering microRNA-214 in mice.Insulin resistance in cavefish as an adaptation to a nutrient-limited environment.E2F1 promotes hepatic gluconeogenesis and contributes to hyperglycemia during diabetes.Investigation of the influence of high glucose on molecular and genetic responses: an in vitro study using a human intestine model.Elevated hepatic expression of H19 long noncoding RNA contributes to diabetic hyperglycemia.DNA methylation in the pathogenesis of type 2 diabetes in humans.PHD3 regulates glucose metabolism by suppressing stress-induced signalling and optimising gluconeogenesis and insulin signalling in hepatocytes
P2860
Q39108134-AE326A9E-44E6-44DC-A6A8-88675DF8F2F2Q39285044-D85FD17D-5A22-4343-8EC0-3BFCAC1E21E0Q39294371-19F6DC96-D15F-489E-B18E-1A0B84170255Q41311783-039C0C3D-3E5E-4302-B6E6-7ED3664B31CBQ41483722-CA9F744D-7AF7-4058-9A63-817EE15C2979Q41609207-A77CC172-DC4C-435C-91E7-7EFB249D7B46Q44871485-86AC5CE3-1326-4AFE-82A1-04A8BCBEB309Q47132703-CC65CC2B-0BB6-41CF-88EE-76DB849E7535Q47738295-56ED4E32-79E9-4D44-A463-3BC5B4F366DCQ48159055-58A143C7-3913-4B86-BE0F-0E00D2388C4CQ48159970-218E7765-7B79-4F8E-B4F2-049D6FA84048Q48165968-F667400B-850D-4C55-881B-4BCBC358E833Q48287561-98D0ED12-224E-4FBE-92D2-ED15A4799827Q48374458-A1B97614-D04B-429B-AAE1-47FB820F7ED0Q49832345-D218A627-B7E2-4920-A650-D75A0E6A6278Q52644784-DF9AD4DD-0AB3-48FF-91D1-0AEEA23EDBEAQ52727321-DD04D6DF-1A73-4E2F-ADC1-D29310ED1CD6Q55004444-337FD1AF-BF4A-4CC7-B71F-96F50926A554Q55285283-086A231F-AAF9-43D5-8026-623FCB892FBEQ55496885-9B8EC685-4F2E-419C-A507-956E43529848Q58700473-E5A9E699-C13A-407B-A950-FB68A773B67F
P2860
Targeting hepatic glucose metabolism in the treatment of type 2 diabetes.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Targeting hepatic glucose metabolism in the treatment of type 2 diabetes.
@en
type
label
Targeting hepatic glucose metabolism in the treatment of type 2 diabetes.
@en
prefLabel
Targeting hepatic glucose metabolism in the treatment of type 2 diabetes.
@en
P2093
P2860
P356
P1476
Targeting hepatic glucose metabolism in the treatment of type 2 diabetes.
@en
P2093
Amy K Rines
Clint D J Tavares
Kfir Sharabi
Pere Puigserver
P2860
P2888
P304
P356
10.1038/NRD.2016.151
P577
2016-08-12T00:00:00Z